Goh Evelyn Mei Ling, Ng Xue Qin, Yong Ching Yee, Hamzah Asimah, Moy Hooi Yan
Department of Drug Abuse Testing, Analytical Toxicology Laboratory, Applied Sciences Group, Health Sciences Authority, 11 Outram Road, Singapore 169078, Singapore.
J Anal Toxicol. 2023 Apr 14;47(4):366-378. doi: 10.1093/jat/bkad006.
Numerous methods and techniques have been published for the identification of new psychoactive substances (NPS) and their metabolites in urine. However, there lacks a holistic approach to analyze different groups of NPS and their metabolites with decision points for reporting their use. In this study, data-dependent acquisition workflow using liquid chromatography--quadrupole time-of-flight mass spectrometry was developed and validated for the identification of a total of 94 NPS and metabolites in urine using the established decision points. The limit of identification for all analytes was determined at 25% below their respective decision points. The method was demonstrated to be accurate and precise at their respective decision points with extraction recoveries and ion suppression/enhancement ranging from 51.0% to 103.5% and -81.6% to 159.1%, respectively. There was no observed carryover up to 200 ng/mL for all analytes and no interferences from urine matrixes, internal standards and other common drugs of abuse. The extracted drug analytes were stable at 4 and 15°C for up to 3 days. The validated method was successfully evaluated and applied in the testing of urine samples from NPS users. In conclusion, this validated method can analyze a wide range of NPS and their metabolites with the use of decision points for consistency in reporting.
目前已发表了许多用于鉴定尿液中新精神活性物质(NPS)及其代谢物的方法和技术。然而,缺乏一种整体方法来分析不同类别的NPS及其代谢物,并给出报告其使用情况的判定点。在本研究中,开发并验证了一种基于液相色谱 - 四极杆飞行时间质谱的数据依赖型采集工作流程,用于使用既定判定点鉴定尿液中的总共94种NPS及其代谢物。所有分析物的鉴定限确定为低于其各自判定点的25%。该方法在各自的判定点处被证明是准确和精确的,萃取回收率和离子抑制/增强分别为51.0%至103.5%和 -81.6%至159.1%。所有分析物在高达200 ng/mL时均未观察到残留,且尿液基质、内标和其他常见滥用药物均无干扰。提取的药物分析物在4℃和15℃下可稳定保存3天。该经过验证的方法已成功用于NPS使用者尿液样本的检测评估。总之,这种经过验证的方法可以利用判定点分析多种NPS及其代谢物,以确保报告的一致性。